
In this phase I study, zzso was administered orally for 20 consecutive days to patients with zzso zzso All patients but one were zzso When given for 20 consecutive days, the maximum tolerated dose of zzso was 100 zzso zzso was the zzso zzso and occurred between days 17 and zzso In all patients blood counts had sufficiently recovered by day 35 to begin another zzso zzso zzso toxicity persisted in 6 of 15 patients despite zzso Total zzso was observed in 10 of 13 patients at zzso We recommend zzso 100 zzso for 20 consecutive days for evaluation of zzso efficacy in phase II zzso 

